Updated:
Korify Capital
Korify Capital blends direct secondaries with venture capital from Malta, covering seed through late-stage expansion.
Korify Capital
Korify Capital focuses on investing in biotechnology ventures and small-sized companies. The firm has made 11 investments, including a Seed VC in Refoxy Pharma on December 04, 2024. Korify Capital has a single portfolio exit, Alto Neuroscience, which exited on February 02, 2024.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Malta
City
Birkirkara
Corporate office
Birkirkara, Malta
Frequently asked questions
What is Korify Capital's core investment strategy?
Korify Capital pursues a dual-mandate private equity strategy combining direct secondary transactions with venture capital. On the secondary side, the firm acquires existing investor positions in private companies, offering liquidity to prior stakeholders. Its venture practice targets primary commitments from seed and startup stages through late-stage expansion rounds, enabling lifecycle-wide exposure to private company growth.
Where is Korify Capital domiciled and why does that matter?
Korify Capital is headquartered in Birkirkara, Malta, an EU member state with a developed regulatory regime for alternative investment fund managers. A Malta domicile allows the firm to passport its funds across the European Economic Area under AIFMD frameworks. This jurisdictional choice signals a European operational focus and access to EU institutional capital flows.
Does Korify Capital focus on specific sectors or geographies?
Public disclosures do not specify sector concentrations or geographic restrictions. The firm's stated stage coverage—seed, startup, expansion, and late-stage venture, alongside direct secondaries—suggests a generalist investment approach. Given its Malta registration, European companies likely form the core of its portfolio, but no explicit regional mandate has been published.
How does Korify Capital's secondary strategy work?
Korify Capital executes direct secondary transactions, acquiring stakes in private companies from existing investors rather than through fund-level secondary purchases. This approach allows the firm to negotiate pricing directly with sellers, often capturing discounts to the most recent primary funding round, while gaining exposure to assets that have already been vetted by prior institutional backers.
Who makes investment decisions at Korify Capital?
The firm has not publicly disclosed its investment committee members, managing partners, or named principals. Available public records do not identify the individuals responsible for sourcing, due diligence, or portfolio management. This absence of personnel disclosure is unusual among active private equity managers but not uncommon for Malta-based alternative investment firms.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: